Telomir Pharmaceuticals, Stock Forecast - Variance

TELO Stock   4.87  0.06  1.25%   
Telomir Stock Forecast is based on your current time horizon. Although Telomir Pharmaceuticals,'s naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Telomir Pharmaceuticals,'s systematic risk associated with finding meaningful patterns of Telomir Pharmaceuticals, fundamentals over time.
  
As of the 30th of December 2024, Payables Turnover is likely to drop to 4.46. As of the 30th of December 2024, Common Stock Shares Outstanding is likely to drop to about 23.7 M.
On December 2, 2024 Telomir Pharmaceuticals, Common had Variance of 0.
Check Telomir Pharmaceuticals, VolatilityBacktest Telomir Pharmaceuticals,Trend Details  

Telomir Pharmaceuticals, Trading Date Momentum

On December 03 2024 Telomir Pharmaceuticals, Common was traded for  4.88  at the closing time. The top price for the day was 5.24  and the lowest listed price was  4.37 . The trading volume for the day was 492 K. The trading history from December 3, 2024 was a factor to the next trading day price boost. The trading price change against the next closing price was 14.82% . The trading price change against the current closing price is 61.88% .
Compare Telomir Pharmaceuticals, to competition

Other Forecasting Options for Telomir Pharmaceuticals,

For every potential investor in Telomir, whether a beginner or expert, Telomir Pharmaceuticals,'s price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Telomir Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Telomir. Basic forecasting techniques help filter out the noise by identifying Telomir Pharmaceuticals,'s price trends.

Telomir Pharmaceuticals, Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Telomir Pharmaceuticals, stock to make a market-neutral strategy. Peer analysis of Telomir Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing Telomir Pharmaceuticals, by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Telomir Pharmaceuticals, Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Telomir Pharmaceuticals,'s price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Telomir Pharmaceuticals,'s current price.

Telomir Pharmaceuticals, Market Strength Events

Market strength indicators help investors to evaluate how Telomir Pharmaceuticals, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Telomir Pharmaceuticals, shares will generate the highest return on investment. By undertsting and applying Telomir Pharmaceuticals, stock market strength indicators, traders can identify Telomir Pharmaceuticals, Common entry and exit signals to maximize returns.

Telomir Pharmaceuticals, Risk Indicators

The analysis of Telomir Pharmaceuticals,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Telomir Pharmaceuticals,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting telomir stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Telomir Pharmaceuticals,

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Telomir Pharmaceuticals, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals, will appreciate offsetting losses from the drop in the long position's value.

Moving together with Telomir Stock

  0.72A Agilent TechnologiesPairCorr

Moving against Telomir Stock

  0.62DRUG Bright Minds BiosciencesPairCorr
  0.5VANI Vivani MedicalPairCorr
  0.44VNDA Vanda PharmaceuticalsPairCorr
  0.43SABSW SAB BiotherapeuticsPairCorr
The ability to find closely correlated positions to Telomir Pharmaceuticals, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Telomir Pharmaceuticals, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Telomir Pharmaceuticals, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Telomir Pharmaceuticals, Common to buy it.
The correlation of Telomir Pharmaceuticals, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Telomir Pharmaceuticals, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Telomir Pharmaceuticals, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Telomir Pharmaceuticals, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Telomir Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Telomir Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Telomir Pharmaceuticals, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Telomir Pharmaceuticals, Common Stock:
Check out Historical Fundamental Analysis of Telomir Pharmaceuticals, to cross-verify your projections.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telomir Pharmaceuticals,. If investors know Telomir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telomir Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.77)
Return On Assets
(2.05)
Return On Equity
(17.53)
The market value of Telomir Pharmaceuticals, is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telomir Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telomir Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telomir Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.